A new multisocietal statement details the ACC and American Heart Association (AHA's) work over the last several years to optimize clinical practice guidelines, and outlines the continued work and ...

Several observations from preclinical and short-term clinical studies support a role for sildenafil in the treatment of heart failure patients. The following discussion briefly considers each of ...

If you have heart failure, it is important for you to know what kinds of symptoms you can experience. By paying close attention to your symptoms, you can help your healthcare provider optimize your ...

The American College of Cardiology Foundation (ACCF) and the American Heart Association (AHA) recently reviewed pivotal trials of the last 5 years and released an update to the 2002 UA/NSTEMI ...

This CardiaCast is part of an educational series, “2024 Update to the AHA/ACC HCM Guideline: Expert Interpretation for Application to Practice,” which includes a total of three ACC CardiaCasts and an ...

Among those with HF history, 47.9% had preserved ejection fraction (HFpEF), 18.1% had reduced ejection fraction (HFrEF), and 33.9% were unclassified. Both patients with and without a history of HF ...

30, 2024 — Scientists discovered that blocking the activity of the hormone glucagon could treat a common and challenging type of heart failure ... A new American Heart Association scientific ...

You are viewing the correction.

The opinions expressed in this article are not necessarily those of the editors or of the American Heart Association. See Article by Kahwash et al. For Disclosures, see page 3. Joseph P, Roy A, Lonn E ...

Among the patients (mean [SD] age, 60.4 [12.8] years), 67.5% were men, 42% were non-White, 84% had heart failure with reduced ejection fraction (HFrEF), and 33.7% had comorbid diabetes.